Literature DB >> 26266831

The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.

Tarryn Willmer1, Jade Peres1, Shaheen Mowla1, Amaal Abrahams1, Sharon Prince1.   

Abstract

The transcription factor, TBX3, is critical for the formation of, among other structures, the heart, limbs and mammary glands and haploinsufficiency of the human TBX3 gene result in ulnar-mammary syndrome which is characterized by hypoplasia of these structures. On the other hand, the overexpression of TBX3 is a feature of a wide range of cancers and it has been implicated in several aspects of the oncogenic process. This includes its ability to function as an immortalizing gene and to promote proliferation through actively repressing negative cell cycle regulators. Together this suggests that TBX3 levels may need to be tightly regulated during the cell cycle. Here we demonstrate that this is indeed the case and that TBX3 mRNA and protein levels peak at S-phase and that the TBX3 protein is predominantly localized to the nucleus of S-phase cells. The increased levels of TBX3 in S-phase are shown to occur transcriptionally through activation by c-Myc at E-box motifs located at -1210 and -701 bps and post-translationally by cyclin A-CDK2 phosphorylation. Importantly, when TBX3 is depleted by shRNA the cells accumulate in S-phase. These results suggest that TBX3 is required for cells to transit through S-phase and that this function may be linked to its role as a pro-proliferative factor.

Entities:  

Keywords:  S-phase; TBX3; c-Myc; cell cycle; cyclin A-CDK2; phosphorylation; transcription

Mesh:

Substances:

Year:  2015        PMID: 26266831      PMCID: PMC4825571          DOI: 10.1080/15384101.2015.1080398

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  50 in total

1.  The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.

Authors:  Merel E Lingbeek; Jacqueline J L Jacobs; Maarten van Lohuizen
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

Review 2.  Rules to replicate by.

Authors:  K A Heichman; J M Roberts
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases.

Authors:  V V Ogryzko; P Wong; B H Howard
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

Review 4.  T-box genes in human disorders.

Authors:  Elizabeth A Packham; J David Brook
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

5.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  UV-mediated regulation of the anti-senescence factor Tbx2.

Authors:  Amaal Abrahams; Shaheen Mowla; M Iqbal Parker; Colin R Goding; Sharon Prince
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

7.  Ectopic Tbx2 expression results in polyploidy and cisplatin resistance.

Authors:  E Davis; H Teng; B Bilican; M I Parker; B Liu; S Carriera; C R Goding; S Prince
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

8.  TBX3 promotes human embryonic stem cell proliferation and neuroepithelial differentiation in a differentiation stage-dependent manner.

Authors:  Taraneh Esmailpour; Taosheng Huang
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

9.  T-box 3 negatively regulates osteoblast differentiation by inhibiting expression of osterix and runx2.

Authors:  K E Govoni; G R Linares; S-T Chen; S Pourteymoor; S Mohan
Journal:  J Cell Biochem       Date:  2009-02-15       Impact factor: 4.429

10.  TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.

Authors:  Natalia Platonova; Maddalena Scotti; Polina Babich; Gloria Bertoli; Elena Mento; Vasco Meneghini; Aliana Egeo; Ileana Zucchi; Giorgio R Merlo
Journal:  Cell Tissue Res       Date:  2007-01-30       Impact factor: 5.249

View more
  13 in total

1.  TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression.

Authors:  Xiaomeng Li; Xianhui Ruan; Peitao Zhang; Yang Yu; Ming Gao; Shukai Yuan; Zewei Zhao; Jie Yang; Li Zhao
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

Review 2.  The roles and regulation of TBX3 in development and disease.

Authors:  Saif F Khan; Victoria Damerell; Rehana Omar; Michelle Du Toit; Mohsin Khan; Hapiloe Mabaruti Maranyane; Mihlali Mlaza; Jenna Bleloch; Claire Bellis; Bianca D B Sahm; Jade Peres; K N ArulJothi; Sharon Prince
Journal:  Gene       Date:  2019-10-26       Impact factor: 3.688

3.  The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes.

Authors:  T Willmer; A Cooper; D Sims; D Govender; S Prince
Journal:  Oncogenesis       Date:  2016-02-22       Impact factor: 7.485

4.  Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC.

Authors:  Jie Ji; Yin Yin; Huanyu Ju; Xiaoliang Xu; Wei Liu; Qiang Fu; Jiaojiao Hu; Xudong Zhang; Beicheng Sun
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

5.  Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/‌Akt‑dependent Tbx‑3 activation pathway.

Authors:  Minxia Ke; Quan He; Danping Hong; Ouyang Li; Mengyi Zhu; Wen-Bin Ou; Yulong He; Yuehong Wu
Journal:  Int J Mol Med       Date:  2018-04-03       Impact factor: 4.101

6.  Transcription box‑3 protects human umbilical vein endothelial cells in a high‑glucose environment through sirtuin 1/AKT signaling.

Authors:  Zhanjiang Yu; Wei Zhang; Xiankun Zhang; Donghui Xu; Na Wang
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

7.  The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor.

Authors:  Tarryn Willmer; Shannagh Hare; Jade Peres; Sharon Prince
Journal:  Cell Div       Date:  2016-04-22       Impact factor: 5.130

8.  Tbx3-dependent amplifying stem cell progeny drives interfollicular epidermal expansion during pregnancy and regeneration.

Authors:  Ryo Ichijo; Hiroki Kobayashi; Saori Yoneda; Yui Iizuka; Hirokazu Kubo; Shigeru Matsumura; Satsuki Kitano; Hitoshi Miyachi; Tetsuya Honda; Fumiko Toyoshima
Journal:  Nat Commun       Date:  2017-09-11       Impact factor: 14.919

9.  The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma.

Authors:  Danica Sims; Hapiloe Mabaruti Maranyane; Victoria Damerell; Dhirendra Govender; Ashwin W Isaacs; Jade Peres; Sharon Prince
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

Review 10.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.